ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q2Hybrid

American Journal of Cancer Research

Abbreviation (ISO):AM J CANCER RES
•
Identifier (ISSN):2156-6976(Print)
•
Publisher:E-CENTURY PUBLISHING CORP
Clarivate IF (2026)
3.1↑ +0.2
Journal Impact Factor
IF Trend↓
WoS Quartile
Q2
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for American Journal of Cancer Research

WoS Q2
2468420184.7420195.1820206.1720215.9420225.320233.620242.920253.12026
Annual Impact Factor Metric
Current (2026):3.1
Scopus SJR & Rank
N/A

SCImago Journal Rank citation prestige weighting

Scopus / Elsevier Data
H-Index (2021)
20

20 papers with at least that number of citations each

WoS: SCIE / JCRQ2
Self-Citation Rate2.8%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
381articles/year
1.75% Gold OA•89.15% Original Research

Aims & Scope

The American Journal of Cancer Research (AJCR) (ISSN 2156-6976), is an independent open access, online only journal to facilitate rapid dissemination of novel discoveries in basic science and treatment of cancer. It was founded by a group of scientists for cancer research and clinical academic oncologists from around the world, who are devoted to the promotion and advancement of our understanding of the cancer and its treatment. The scope of AJCR is intended to encompass that of multi-disciplinary researchers from any scientific discipline where the primary focus of the research is to increase and integrate knowledge about etiology and molecular mechanisms of carcinogenesis with the ultimate aim of advancing the cure and prevention of this increasingly devastating disease. To achieve these aims AJCR will publish review articles, original articles and new techniques in cancer research and therapy. It will also publish hypothesis, case reports and letter to the editor. Unlike most other open access online journals, AJCR will keep most of the traditional features of paper print that we are all familiar with, such as continuous volume, issue numbers, as well as continuous page numbers to retain our comfortable familiarity towards an academic journal.

Topics Covered (Recognized by AI)
Biology99.8%Medicine99.3%Genetics98.5%Internal medicine93.9%Chemistry86.7%Cancer research85.6%Biochemistry84.4%Cancer79.9%Gene63.5%Pathology41.2%Cell biology36.8%Apoptosis36%Immunology35.3%Oncology29.7%Surgery23.9%Cell culture23.3%Cell23%Metastasis20.4%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

ONCOLOGY

Q2
Rank165/333
IndexSCIE
JCISCIE2026

ONCOLOGY

Q3
Rank177/333
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

9 year
2026Latest
IF3.1
Articles / Year214
Total Citations129
2025
IF2.9
Articles / Year373
Total Citations647
2024
IF3.6
Articles / Year387
Total Citations1,883
2023
IF5.3
Articles / Year—
Total Citations—
2022
IF5.942
Articles / Year1
Total Citations34

SCImago & Scopus Journal Intelligence

Not indexed in SCImago / Scopus database

This journal is currently not indexed in Scopus or is an academic publication indexed exclusively in Web of Science (WoS).

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 2.8%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
3区 (Zone 3)Medicine
Minor Category (Specific Field):
3区ONCOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
In warning list
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

American Journal of Cancer Research (abbr: AM J CANCER RES, ISSN: 2156-6976) is a peer-reviewed international scholarly journal in the field of ONCOLOGY, published by E-CENTURY PUBLISHING CORP in United States. The periodical holds a Journal Impact Factor (JIF) of 3.10, ranking in quartile Q2 of Web of Science (SCIE), an H-index of 20.

The journal enforces rigorous peer evaluation with an annual output of approximately 381 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with APC fees are not specified. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
E-CENTURY PUBLISHING CORP
Publication Language
English
Frequency
Periodic
Indexing & Databases
SCIEPubMed
Editorial Address
40 WHITE OAKS LN, MADISON, USA, WI, 53711

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 61997bef-3ac2-453d-bd49-9dfcf1a00bbf
Database Updated: 2026-09-29